Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Diana Shipping Inc. Cautions of Significant Downside Risk in Genco’s Share Price
-
IREN Acquires Awaken to Support Global Brand Growth
-
INNEOVA Holdings Reports Fiscal Year 2025 Financial Results; Operating Cash Flow Increases 75% as Engineering Transformation Advances
-
Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
-
Onfolio Holdings Inc. Announces Q1 2026 Financial Results and Provides Corporate Update
-
Denodo Advances Trusted Data Foundations for Agentic AI with New Amazon Web Services (AWS) Integrations
-
Orion Group Holdings Announces Conference Participation
-
One Fire, Many Flames: The Immune Response Fueling Allergic and Inflammatory Diseases
-
Brady Corporation Reports Record Adjusted EPS in its Fiscal 2026 Third Quarter and Raises its Fiscal 2026 Adjusted EPS Guidance
-
BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting
-
Ashland Board appoints Bertrand Loy as new director
-
Solera Supercharges Inventory+ with Deep OVE Integration, Automating Wholesale Syndication and Helping Dealers Move Aged Units Faster
-
Nekoosa School District Announces Strategic Partnership with Edustaff to Strengthen Educator Staffing Solutions
-
Badass Capital Launches New AI-First Hedge Fund, Targeting Sports Betting, Trading, and Prediction Markets
-
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market
-
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
-
SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting
-
U.S. Personal Care Products Industry Drives Nearly $500 Billion in Economic Output, Supports More Than 2.6 Million Jobs, New Report Finds
-
GXO recognized once again by Forbes as one of the Best Places to Work in Spain in 2026
-
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
-
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
-
Quantum Cyber to Exhibit at Special Operations Forces Week 2026
-
Sitryx to Participate in Upcoming Investor Conferences
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Man Group PLC : Form 8.3 - DCC Plc
-
Bitget IPO Prime Taps Into $4T AI Opportunity With OpenAI
-
Man Group PLC : Form 8.3 - Bluefield Solar Income Fund Ltd
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Man Group PLC : Form 8.3 - AMG Lithium B.V. (a direct wholly-owned subsidiary of AMG Critical Materials N.V.)
-
Form 8.3 -TATE & LYLE PLC
-
Man Group PLC : Form 8.3 - Senior plc
-
Genco Shipping & Trading Limited Sends Letter to Shareholders from Chairman and CEO John Wobensmith
-
JDE Peets notice of results of consent solicitations in respect of outstanding euro notes
-
Lassila & Tikanoja strengthens its waste management services by acquiring Kempeleen Siirtokuljetus Oy and Kempeleen Jätekuljetus Oy
-
GMR Solutions Inc. Announces Ratings Upgrade and Debt Reduction
-
Genco Shipping & Trading Limited Sends Letter to Shareholders from Chairman and CEO John Wobensmith
-
Ring Energy to Participate in Water Tower Research Fireside Chat on May 20, 2026
-
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
-
Castellum Reminds Stockholders to Submit Their Vote at Its Upcoming 2026 Annual Meeting
-
MiddleGround Capital Announces Firmwide Promotions; Elevates Roland Veldhuijzen van Zanten to Managing Director
-
Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies
-
Transaction in Own Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BEAZLEY PLC - Ordinary Shares
-
Share buy-back program

